Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:12 pm Sale |
2024-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
Venrock Healthcare Capital Partners III L.P. | 2,629,786 2.900% |
-2,925,769 (-52.66%) |
Filing |
| 2024-04-01 6:21 pm Purchase |
2024-03-22 | 13G | Aquestive Therapeutics, Inc. AQST |
Venrock Healthcare Capital Partners III L.P. | 5,555,555 6.500% |
5,555,555 (New Position) |
Filing |